This metabolic phenotype is characterized by a favorable cardiometabolic risk profile and more specifically, reduced incidence of metabolic syndrome and obesity with a favorable lipid and insulin profile. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.